Lexapro can be continued during pregnancy, but requires careful evaluation with your healthcare provider. Studies show that untreated depression during pregnancy carries significant risks including preterm birth, low birth weight, and developmental delays. Research indicates that selective serotonin reuptake inhibitors like Lexapro have a relatively low risk profile compared to untreated maternal depression. The FDA classifies Lexapro as a Category C medication, meaning potential benefits may warrant use despite potential risks. Your doctor will weigh factors including depression severity, previous treatment responses, and trimester timing to determine the safest approach for both you and your baby.
Should I stop antidepressants before trying to conceive?
Can Lexapro affect my baby's development?
What alternatives to Lexapro are safe during pregnancy?
This comprehensive guide examines the latest research on using antidepressant medications during pregnancy. It covers safety data for different drug classes and helps expectant mothers make informed decisions.
Explores evidence-based non-pharmaceutical approaches to treating depression during pregnancy including therapy options and lifestyle interventions. Provides practical strategies for maintaining mental health naturally.
Details how pregnancy medication decisions can impact postpartum mental health outcomes. Covers screening, early intervention strategies, and treatment options for new mothers experiencing depression.
Understanding Doxycycline and Lyme Disease TreatmentFinding a tick attached to your skin triggers immediate worry. Should you take antibiotics? How long do you have to act? [...]
Read MoreWhat Hives and Heat Have in CommonIf you break out in small, intensely itchy bumps every time you exercise, step into a hot shower, or spend time in sweltering weather, you [...]
Read MoreWhat Happens After a Tick BiteFinding a tick embedded in your skin creates immediate anxiety. Should you rush to a doctor for doxycycline after a tick bite, or is watchful [...]
Read More
